Trial site
OCT Research ULC (dba Okanagan Clinical Trials)
- 1running trial
- 9closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease7 trials
- Mild cognitive impairment2 trials
- Type 2 diabetes2 trials
- Autism1 trial
- Obesity1 trial
- Phase
- Phase 37 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Terminated4 trials
- Active, not recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S4 trials
- Alzheon Inc.2 trials
- Cassava Sciences, Inc.2 trials
- MapLight Therapeutics1 trial
- Neurim Pharmaceuticals Ltd.1 trial
Running trials
Closed trials
Terminated
Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
Completed
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Terminated
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Site data: ClinicalTrials.govUpdated 17 Nov 2026